Biopharmaceutical Company Alimera Sciences Inc. said the Austrian health regulator approved its experimental drug Iluvien for retinal swelling, raising hopes for the company's most advanced treatment, which has been twice rejected in the United States.The drug was approved for chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies. Iluvien is a sustained
Bharat | Submitted ![](/templates/wistie/images/rss.gif)
Alimera Eye Drug Inches Closer to Launch With Austria Approval
Posted by Bharat (#1) 4439 days ago (Editorial)Climate Change 'Is Harming Eye Health'
Posted by Bharat (#1) 4439 days ago (Editorial)
GLOBAL WARMING Warming of the Earth's climate system and related increasing concentrations of greenhouse gasses are causing some eye disorders. According to the World Health Organisation (WHO), of the 18 million people worldwide who have cataract-related diseases, 5% are directly attributable to UV radiation. UVA light, a component of UV radiation, stimulates the over-production of damaging oxyge
UV Protection Critical for Eye Health
Posted by Bharat (#1) 4439 days ago (Editorial)
Summer is on its way, but most Americans don't recognize the importance of ultraviolet (UV) protection for their eyes to prevent damage and visual impairment. In fact, according to the American Optometric Association's (AOA) recent American Eye-Q® survey, only 47 percent of Americans said UV protection is the most important factor when purchasing sunglasses. Additionally, less than one-third (28
Major Breakthrough In Macular Degeneration Research
Posted by Bharat (#1) 4439 days ago (Editorial)
University of Kentucky researchers, led by Dr. JayakrishnaAmbati, have made a major breakthrough in the "dry" form of age-related macular degeneration known as geographic atrophy (GA). GA is an untreatable condition that causes blindness in millions of individuals due to death of retinal pigmented epithelial cells. The paper, "DICER1 loss and Alu RNA Induce Age-Related Macular Degeneration via th
First Oral Agent To Quell Invasive Macular Degeneration, Restore Lost Vision
Posted by Bharat (#1) 4441 days ago (Editorial)
There may be new found hope for patients whose vision is threatened when medicine injected directly into the eyes fails to cause abnormal blood vessels to recede. While injectable drugs called angiogenesis (an-gee-oh-jen-esis) inhibitors are considered a modern miracle and have become the standard of care for patients with the fast-progressive form of macular degeneration, they are not foolproof.
First oral agent may rapidly restore lost vision
Posted by Bharat (#1) 4441 days ago (Editorial)
There may be new found hope for patients whose eyesight is threatened when medicine injected directly into the eyes is unsuccessful in causing abnormal blood vessels to recede.While injectable drugs called angiogenesis (an-gee-oh-jen-esis) inhibitors are considered a modern miracle and have become the standard of care for patients with the fast-progressive form of macular degeneration, they are n
Healthy Vision Month 2012: Tips for Maintaining Your Eye Health
Posted by Bharat (#1) 4441 days ago (Editorial)
According to the latest CDC data, more than 61 million adults in the US – or 20 percent of the population – are at high risk for serious vision loss, but only half have seen an eye doctor in the last year.In order to promote proper eye care and eye health awareness, the National Eye Institute has designated May as Healthy Vision Month. 10 things the National Eye Institute advises you should do to
Transplantation Of Fetal Membrane To Prevent Blindness
Posted by Bharat (#1) 4441 days ago (Editorial)
Transplanting tissue from newborn fetal membranes prevents blindness in patients with a devastating disease called Stevens-Johnson syndrome, a Loyola University Medical Center study has found. The study by senior author Charles Bouchard, MD, and colleagues is published online ahead of print in the journal Cornea.
Between 50 percent and 81 percent of SJS/TEN patients experience eye problems, rang
Between 50 percent and 81 percent of SJS/TEN patients experience eye problems, rang